Immediate Impact

1 by Nobel laureates 2 from Science/Nature 50 standout
Sub-graph 1 of 24

Citing Papers

The immunology of type 1 diabetes
2024 Standout
Strategies for targeting cytokines in inflammatory bowel disease
2024 Standout
1 intermediate paper

Works of Ed Rytina being referenced

The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
2018

Author Peers

Author Last Decade Papers Cites
Ed Rytina 158 137 108 37 518
K. Aroni 110 190 71 44 542
Thomas Konia 141 193 96 43 556
E. Bonifazi 74 225 138 41 568
Alice Verdelli 99 147 145 50 503
H.-P. Horny 161 73 133 32 557
M. Dandurand 159 173 80 47 626
S Morii 52 110 62 39 605
Tammie Ferringer 164 233 113 47 626
Bruno E. Paredes 164 250 176 31 543
M. Yadira Hurley 99 188 144 52 637

All Works

Loading papers...

Rankless by CCL
2026